DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,748,361 | -50.0% | 7,047 | -51.6% | 0.33% | -45.2% |
| Q2 2023 | $3,496,320 | -10.3% | 14,568 | -5.8% | 0.60% | -12.1% |
| Q1 2023 | $3,898,303 | -55.1% | 15,467 | -52.8% | 0.69% | -57.1% |
| Q4 2022 | $8,690,382 | -40.6% | 32,742 | -42.2% | 1.60% | -40.9% |
| Q3 2022 | $14,636,000 | +75.0% | 56,665 | +71.8% | 2.71% | +79.5% |
| Q2 2022 | $8,362,000 | -64.0% | 32,983 | -58.3% | 1.51% | -51.1% |
| Q1 2022 | $23,214,000 | -2.1% | 79,141 | +9.8% | 3.09% | +13.8% |
| Q4 2021 | $23,705,000 | -0.2% | 72,050 | -7.7% | 2.71% | +9.2% |
| Q3 2021 | $23,754,000 | -32.9% | 78,024 | -40.8% | 2.48% | -19.3% |
| Q2 2021 | $35,397,000 | -17.5% | 131,900 | -30.8% | 3.08% | -14.9% |
| Q1 2021 | $42,890,000 | +97377.3% | 190,555 | +97121.9% | 3.62% | +120466.7% |
| Q4 2020 | $44,000 | -99.6% | 196 | -99.6% | 0.00% | -99.7% |
| Q3 2020 | $11,507,000 | -39.4% | 53,436 | -50.2% | 0.94% | -39.4% |
| Q2 2020 | $18,986,000 | -25.6% | 107,367 | -41.8% | 1.55% | -31.5% |
| Q1 2020 | $25,524,000 | -44.7% | 184,409 | -38.7% | 2.26% | -24.0% |
| Q4 2019 | $46,156,000 | -35.1% | 300,732 | -38.9% | 2.97% | -36.6% |
| Q3 2019 | $71,140,000 | +1.1% | 492,556 | +0.1% | 4.69% | +3.6% |
| Q2 2019 | $70,350,000 | +9.5% | 492,234 | +1.1% | 4.52% | +16.1% |
| Q1 2019 | $64,259,000 | – | 486,737 | – | 3.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |